Objective: To monitor yeasts isolated from women during and between episode
s of recurrent vulvo-vaginal candidosis (WC) to determine whether vaginal r
elapse or re-infection occurred.
Methods: Women presenting at the genitourinary medicine clinic with signs a
nd symptoms of VVC were recruited to the study (n = 121). A vaginal washing
, high vaginal swab (HVS) and rectal swab were taken and the women treated
with a single 500 mg clotrimazole pessary. Women were asked to re-attend af
ter 1, 4, and 12 weeks, or when the WC recurred, when vaginal washings and
HVS were repeated. Candida isolates recovered were strain typed using the C
a3 probe and their similarity assessed. Antifungal susceptibility to flucon
azole and clotrimazole were determined.
Results: Of the women recruited, 47 completed the study, either returning f
or four visits or suffering a recurrence during the study period. Of the 22
women who experienced recurrence, the same strain was responsible for the
initial and recurrent episode in 17 women. For the remaining five women, fo
ur had strain replacement and one had a change of species. None of the isol
ates recovered from the women demonstrated resistance to either clotrimazol
e or fluconazole.
Conclusions: Our findings support the theory of vaginal relapse and thus ma
y support thr use of more prolonged courses of antifungal therapy initially
to increase the chances of eradication of the yeast.